コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 d not affect the amyloidogenic processing of amyloid beta protein precursor.
2 ical beta-secretase cleavage site within the amyloid beta-protein precursor.
3 the Kunitz-type protease inhibitor domain of amyloid beta-protein precursor.
5 he familial Alzheimer's disease gene product amyloid beta protein precursor (A beta PP) is sequential
6 or IXa and Factor XIa (ie, protease nexin-2/ amyloid beta-protein precursor, A beta PP) in the organi
10 ed increase in the levels of cell-associated amyloid beta-protein precursor (AbetaPP) and cell death.
14 ease-causing mutations in the genes encoding amyloid beta protein precursor and presenilins, raising
16 nal presenilins and cleaves substrates (e.g. amyloid beta-protein precursor and Notch) with very loos
17 I integral membrane proteins, including the amyloid beta-protein precursor and the Notch receptor, a
18 I integral membrane proteins, including the amyloid beta-protein precursor and the Notch receptor.
19 ns of a variety of substrates, including the amyloid beta-protein precursor and the Notch receptor.
20 eta1-40 or Abeta1-42 in the absence of human amyloid beta protein precursor (APP) overexpression.
21 were then tested in acute dosing studies in amyloid beta protein precursor (APP) transgenic mice, an
22 en shown to influence limited proteolysis of amyloid beta protein precursor (APP), Notch and ErbB4, a
24 vidence suggests that dysregulated levels of amyloid beta-protein precursor (APP) and its catabolites
25 rous type I membrane proteins, including the amyloid beta-protein precursor (APP) and the Notch recep
26 se A beta is produced from the processing of amyloid beta-protein precursor (APP) by beta- and gamma-
28 protein (Abeta) is released from the larger amyloid beta-protein precursor (APP) by unidentified enz
29 Protease nexin-2 (PN-2), a soluble form of amyloid beta-protein precursor (APP) containing a Kunin
31 nic mouse models that coexpress human PS and amyloid beta-protein precursor (APP) genes and analyzed
32 idation of the proteolytic processing of the amyloid beta-protein precursor (APP) has revealed that o
33 e presenilin 1 (PS1), presenilin 2 (PS2) and amyloid beta-protein precursor (APP) mutations linked to
34 ated with Alzheimer disease, is derived from amyloid beta-protein precursor (APP) through sequential
36 own to attenuate amyloidogenic processing of amyloid-beta protein precursor (APP) in cell culture stu
37 P) binds to and regulates the translation of amyloid-beta protein precursor (App) mRNA, but the detai
40 ther LRP ligands, APOE and APP (encoding the amyloid beta-protein precursor), have now all been genet
42 nd able to produce amyloid beta-peptides and amyloid beta-protein precursor intracellular domain.
44 is of a variety of substrates, including the amyloid beta-protein precursor of Alzheimer's disease an
45 agulant protein, an aprotinin mutant (6L15), amyloid beta-protein precursor, or tissue factor pathway
46 , the Abeta parent molecule protease nexin-2/amyloid beta-protein precursor (PN-2/AbetaPP), which is
49 peptide inhibitors and designed to mimic the amyloid beta-protein precursor substrate bind specifical
50 s of presenilin familial AD mutations on the amyloid beta-protein precursor, the presenilins themselv
52 ate the possibility that caspase cleavage of amyloid beta-protein precursor with the generation of C3
53 mice, an AD mouse model overexpressing human amyloid beta-protein precursor with the Swedish double m